NIH Seeks Comments on Genetic Test Forms
Published Date: 6/30/2026
Notice
Summary
The NIH wants your thoughts on updating forms that help track genetic tests in their registry. If you’re involved in genetic testing or research, these changes could affect how you share info. You’ve got until July 30, 2026, to send in your comments—no cost, just your voice to help make things smoother and smarter!
Analyzed Economic Effects
1 provisions identified: 0 benefits, 1 costs, 0 mixed.
NIH Seeks 3-Year OMB Approval; Time Burden
The NIH proposes to reinstate without change the information-collection forms for the Genetic Testing Registry (OMB control 0925-0651) and requests OMB approval for 3 years. If you are a test developer, manufacturer, researcher, or laboratory personnel who voluntarily submits to the GTR, there are no monetary costs but your time is required — the total estimated annualized burden is 5,217 hours. Submit comments by July 30, 2026.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-12844 — Center for Scientific Review; Notice of Closed Meetings
The NIH’s Center for Scientific Review is holding several closed virtual meetings on July 17, 2026, to review important grant applications. These meetings protect private info and trade secrets while deciding which science projects get funding. Researchers applying for grants in brain injury, neurobehavior, nanotech, and heart/lung studies should note these review dates and prepare accordingly.
2026-12843 — Government Owned Inventions Available for License: C8166-45 Cell Line
The National Cancer Institute is offering a special human T-cell line called C8166-45 for licensing. This cell line helps scientists study viruses like HTLV-1 and HIV, which can cause serious diseases. Researchers and companies can now use this tool to develop better treatments, with licensing info available starting June 2026—no patents, just pure science power ready to roll!
2026-12842 — Government Owned Inventions Available for License: Compositions and Methods for Producing Dendritic Cell-based Vaccines With Enhanced Efficacy
The National Cancer Institute has created a new way to make cancer vaccines stronger by using special omega-3 fats to boost immune cells called dendritic cells. This could help scientists and companies develop better cancer treatments that work more effectively. If you’re in biotech or medicine, now’s the time to team up or license this exciting technology and help bring improved vaccines to patients faster.
2026-12565 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in July 2026 to review and decide on important research grant applications. These meetings protect private info and trade secrets while helping decide who gets funding for cool science projects. If you’re a researcher waiting on grants, these reviews shape the future of your funding and the science world!
2026-12585 — Submission for OMB Review; 30-Day Comment Request; Chimpanzee Research Use Form (Office of the Director)
The NIH wants to keep collecting info using the Chimpanzee Research Use Form and is asking the public to share thoughts by July 23, 2026. This form helps track how chimpanzees are used in research, affecting scientists and animal welfare groups. No big changes or costs are expected, just a smooth extension of the current form’s approval.
2026-12244 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in July 2026 to review and decide on important research grant applications. These meetings protect private info and trade secrets while helping decide funding for health research projects. Scientists and researchers applying for grants should note these dates as they impact which projects get money.
Previous / Next Documents
Previous: 2026-13203 — Notice of Petition for Extension of Waiver of Compliance
SEPTA asked for more time between certain train safety tests and to skip some daily checks on their special trains with smart control systems. This change could save time and effort without risking safety. People can share their thoughts on this by August 31, 2026.
Next: 2026-13209 — Notice of Petition for Extension of Waiver of Compliance
CSX Transportation wants to keep skipping some safety tests on their high-tech railroad signals from every 2 years to every 4 years. This extension affects how often they check important microprocessor-based signal systems, helping them save time and money. The public can share their thoughts by August 31, 2026, before the Federal Railroad Administration decides.